Therapixel

Dear LinkedIn followers, we're pleased to announce the creation of our new profile on Blue Sky! Don't hesitate to give us a follow and share interesting articles with us! Find us here: https://lnkd.in/gCQJj2Bj #connection #socialmedia #radiology

2024 is almost over, and we're excited for what 2025 has in store! Here at Therapixel, we want to spread some holiday cheer and wish you all a very happy holiday season. We're incredibly grateful for our amazing colleagues' hard work and dedication, and we're especially thankful for the trust and loyalty of our wonderful employees. Happy Holidays to each and every one of you!

Could AI transform how we detect breast cancer? While regular mammograms remain key to discovering breast cancer when it’s most treatable, the use of artificial intelligence, such as our Genius AI Detection solution, to interpret the results of these tests is rapidly becoming an important tool for healthcare providers in the fight against the disease. Learn how AI-driven technology is helping radiologists spot areas of concern in challenging clinical scenarios and prioritize cases for review, leading to earlier breast cancer treatment and more lives saved. https://ow.ly/QO8u50Uv9WM #HealthcareInnovation #BreastCancer #ArtificialIntelligence

AI has proven beneficial in the fight against breast cancer, by helping radiologists in their readings and diagnosis decisions. Today, our #caseoftheweek highlights the difference of AI's use in 2D and 3D imaging. Read all about it here: https://bit.ly/4gnHE6V #AI #radiology #technology #medtech #innovation

Avec l'IA, la détection des cancers du sein est facilité de plus en plus. Dans notre #casdelasemaine, il s'agit d'observer l'aide qu'apporte MammoScreen quant il en vient à la détection avec 2D et 3D. Découvrez les détails du cas ici: https://bit.ly/41L28SW #IA #radiologie #TOMO #medtech #innovation

I'm excited to share our latest research on a multi-instant, multimodal (FFDM and DBT) AI for breast cancer screening able to output both interpretive and noninterpretive functions. The system is able to leverage FFDM, DBT, and prior mammograms to provide radiologists not only with super accurate detections of lesions suspicious for breast cancer, but also a wide range of information to expediate the reporting of the case (quadrant, depth, distance from nipple, and finding type between mass/asymmetries, calcifications and distortions). In this MRMC, we observe not only a massive gain in AUC/sens/spec of the readers (e.g., +7% of AUC) across a wide range of fellow breast radiologists, but also a more consistent reporting of the case. Less inter-expert variability in reporting can lead to reduced errors in follow-up examinations and eventually better patient care. Last but not least, a realistic 24% reduction on reading/reporting time and lowered fatigue was also observed during the study. Congrats to Serena Pacilè, Svati Singla Long, and the whole Therapixel crew for this outstanding achievement! https://lnkd.in/da8KgqBT

Merci à tous et toutes qui sont venus nombreux nous voir au #CoursImagerieduSein! Notre équipe a été ravie de vous accueillir et de répondre à vos questions, et vous faire découvrir tous les attraits de MammoScreen. Merci aux organisateurs de leur accueil et du ballet logistique qui a permis à cette édition de #CIS de briller. #IA #MammoScreen #medtech

Looking to boost your team's performance? The right tools can make all the difference! Discover how our MammoScreen platform, an efficient and user-friendly solution for any radiology service with a mammography program, can revolutionize your team's workflow. Ready to see it in action? Schedule a demo today! https://bit.ly/4b4WoVz 💡🚀 #Productivity #Radiology #MammoScreen

Dernière journée pour venir rencontrer notre équipe avec Bruno PICAVET Lucía Pérez García afin de discuter radiologie, détection du cancer du sein, et comment Mammoscreen peut améliorer le quotidien dans votre cabinet. Ne manquez pas de venir nous voir dans le hall d’exposition du #CIS2024!  #IA #MammoScreen #medtech

L’équipe Therapixel est prête pour la première journée au #CIS! Venez poser toutes vos questions au stand #, et découvrez comment MammoScreen, l’IA de sénologie la plus utilisée en France avec la plus longue expérience de l'usage de l'antériorité, peut vous aider en matière de détection du cancer du sein #IA #MammoScreen #medtech